Winfield Associates’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1
| Closed | -$1K | – | 689 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 805 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 904 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 922 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 800 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 780 |
|
|
2016
Q3 | $0 | Sell |
1
-10
| -91% | – | ﹤0.01% | 739 |
|
|
2016
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 664 |
|
|
2016
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 652 |
|
|
2015
Q4 | $2K | Hold |
11
| – | – | ﹤0.01% | 289 |
|
|
2015
Q3 | $2K | Hold |
11
| – | – | ﹤0.01% | 290 |
|
|
2015
Q2 | $7K | Hold |
11
| – | – | ﹤0.01% | 247 |
|
|
2015
Q1 | $5K | Hold |
11
| – | – | ﹤0.01% | 264 |
|
|
2014
Q4 | $6K | Hold |
11
| – | – | ﹤0.01% | 262 |
|
|
2014
Q3 | $16K | Buy |
11
+5
| +83% | +$7.27K | 0.01% | 213 |
|
|
2014
Q2 | $7K | Buy |
+6
| New | +$7K | 0.01% | 260 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 291 |
|